MedPath
HSA Approval

APO-ZIDOVUDINE CAPSULE 100 mg

SIN07438P

APO-ZIDOVUDINE CAPSULE 100 mg

APO-ZIDOVUDINE CAPSULE 100 mg

May 24, 1993

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J05AF01

zidovudine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

ZIDOVUDINE

100 mg

Zidovudine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-ZIDOVUDINE CAPSULE 100 mg - HSA Approval | MedPath